Second bone marrow transplantation for patients with thalassemia: risks and benefits.
作者信息
Stepensky Polina, Or Reuven, Shapira Michael Y, Revel-Vilk Shoshana, Stein Jerry, Resnick Igor B
出版信息
Haematologica. 2009 Sep;94(9):1329-30. doi: 10.3324/haematol.2009.006817.
Abstract
摘要
相似文献
1
Second bone marrow transplantation for patients with thalassemia: risks and benefits.地中海贫血患者的第二次骨髓移植：风险与益处
Haematologica. 2009 Sep;94(9):1329-30. doi: 10.3324/haematol.2009.006817.
2
Allogeneic stem cell transplantation for thalassemia major.重型地中海贫血的异基因干细胞移植
Haematologica. 2008 Dec;93(12):1780-4. doi: 10.3324/haematol.2008.001909.
3
Hematopoietic cell transplantation for thalassemia: a global perspective BMT tandem meeting 2013.地中海贫血的造血细胞移植：全球视角 BMT 串联会议 2013 年
Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S70-3. doi: 10.1016/j.bbmt.2012.10.025. Epub 2012 Oct 27.
4
Hematopoietic cell transplantation for hemoglobinopathies.血红蛋白病的造血细胞移植
Curr Probl Pediatr Adolesc Health Care. 2008 Jan;38(1):6-18. doi: 10.1016/j.cppeds.2007.10.002.
5
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.使用定制的基于白消安的预处理方案进行先天性血红蛋白病的异基因干细胞移植：单中心经验
Biol Blood Marrow Transplant. 2016 Jun;22(6):1043-1048. doi: 10.1016/j.bbmt.2016.03.003. Epub 2016 Mar 23.
6
Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism.
Br J Haematol. 1996 Aug;94(2):285-7. doi: 10.1046/j.1365-2141.1996.d01-1797.x.
7
[Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].[异基因造血干细胞移植治疗重型β地中海贫血]
Zhonghua Xue Ye Xue Za Zhi. 2003 Apr;24(4):174-6.
8
Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation.创新的β地中海贫血治疗方法：基因治疗与异体造血干细胞移植的成本效益分析。
Hum Gene Ther. 2019 Jun;30(6):753-761. doi: 10.1089/hum.2018.178. Epub 2019 May 3.
9
ABO incompatibility and bone marrow transplantation in children with thalassemia major.
Pediatr Transplant. 2016 Feb;20(1):180-1. doi: 10.1111/petr.12624. Epub 2015 Nov 19.
10
Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience.β地中海贫血的骨髓移植：加利福尼亚大学旧金山分校的经验
J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):598-601. doi: 10.1097/00043426-200011000-00030.
引用本文的文献
1
Successful Second Hematopoietic Stem Cell Transplantation Using Total Body Irradiation-Based Conditioning for Children With Transfusion-Dependent Beta-Thalassemia.采用基于全身照射的预处理方案成功进行第二次造血干细胞移植治疗输血依赖型β地中海贫血患儿
J Hematol. 2025 Feb;14(1):26-31. doi: 10.14740/jh1378. Epub 2025 Jan 25.
2
Second BMT for thalassemia major using CY post transplant.
Bone Marrow Transplant. 2014 Jun;49(6):845-6. doi: 10.1038/bmt.2014.36. Epub 2014 Mar 10.
3
HLA-matched sibling bone marrow transplantation for β-thalassemia major.HLA 配型同胞骨髓移植治疗重型β地中海贫血。
Blood. 2011 Feb 3;117(5):1745-50. doi: 10.1182/blood-2010-09-306829. Epub 2010 Nov 30.
本文引用的文献
1
Allogeneic stem cell transplantation for thalassemia major.重型地中海贫血的异基因干细胞移植
Haematologica. 2008 Dec;93(12):1780-4. doi: 10.3324/haematol.2008.001909.
2
Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft.首次移植排斥后复发的地中海贫血患者的第二次造血干细胞移植。
Bone Marrow Transplant. 2008 Sep;42(6):397-404. doi: 10.1038/bmt.2008.175. Epub 2008 Jun 23.
3
Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT.造血干细胞移植后输血依赖型地中海贫血患者的生活质量
Bone Marrow Transplant. 2008 Sep;42(5):319-27. doi: 10.1038/bmt.2008.165. Epub 2008 Jun 16.
4
Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.在重型地中海贫血患者中，使用基于氟达拉滨的低毒性方案进行来自匹配的亲属和非亲属供体的异基因干细胞移植。
Bone Marrow Transplant. 2007 Nov;40(10):957-64. doi: 10.1038/sj.bmt.1705826. Epub 2007 Sep 10.
5
Beta-thalassemia.β地中海贫血
N Engl J Med. 2005 Sep 15;353(11):1135-46. doi: 10.1056/NEJMra050436.
6
Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.减低强度造血干细胞移植治疗儿童非恶性疾病
Lancet. 2004;364(9429):156-62. doi: 10.1016/S0140-6736(04)16628-2.
7
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.镰状细胞贫血和β地中海贫血患者的微毒性非清髓性移植结果。
Biol Blood Marrow Transplant. 2003 Aug;9(8):519-28. doi: 10.1016/s1083-8791(03)00192-7.
8
Second marrow transplants for graft failure in patients with thalassemia.地中海贫血患者移植失败后的二次骨髓移植。
Bone Marrow Transplant. 1999 Dec;24(12):1299-306. doi: 10.1038/sj.bmt.1702076.
Zotero 插件